SCHEMBL1698458

SCHEMBL1698458

COCCC(=O)NC1CCCCC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.68
MAPT P10636 1/20 0.61
SMN1; SMN2 Q16637 3/20 0.60
ALDH1A1 P00352 1/20 0.59
HPGD P15428 3/20 0.58
EPHX2 P34913 3/20 0.57
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
EPHX1 P07099 1/20 0.52
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23135469 0.98 NPSR1 (0.65) NPSR1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL23135468 0.94 NPSR1 (0.59) NPSR1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL23135471 0.90 NPSR1 (0.53) NPSR1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL17226492 0.89 SMN1; SMN2 (0.67) NPSR1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL12385841 0.84 RAB9A (0.51) NPSR1MAPTSMN1; SMN2EPHX1
SCHEMBL15431414 0.84 RAB9A (0.51) NPSR1MAPTSMN1; SMN2EPHX1
SCHEMBL10587847 0.82 ALDH1A1 (0.83) NPSR1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL1698336 0.81 NPSR1 (1.00) NPSR1SMN1; SMN2ALDH1A1HPGDEPHX2
SCHEMBL2097679 0.81 NPSR1 (1.00) NPSR1SMN1; SMN2ALDH1A1HPGDEPHX2
SCHEMBL2091358 0.81 NPSR1 (1.00) NPSR1SMN1; SMN2ALDH1A1HPGDEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109363-A1 COMPOSITION CONTAINING HIGHLY SAFE AMIDE COMPOUND KJ CHEMICALS CORPORATION (JP) 2025-04-03 US disclosed
EP-4491674-A1 COMPOSITION CONTAINING HIGHLY SAFE AMIDE COMPOUND KJ Chemicals Corporation (JP) 2025-01-15 EP disclosed
CN-118765309-A Composition containing high-safety amide compound 科巨希化学股份有限公司 2024-10-11 CN disclosed
US-20230406986-A1 SOLVENT FOR RESIN SYNTHESIS AND METHOD FOR PRODUCING SYNTHETIC RESIN USING SAID SOLVENT KJ CHEMICALS CORPORATION (JP) 2023-12-21 US disclosed
WO-2023171679-A1 COMPOSITION CONTAINING HIGHLY SAFE AMIDE COMPOUND KJケミカルズ株式会社 2023-09-14 WO disclosed
EP-4212574-A1 SOLVENT FOR RESIN SYNTHESIS AND METHOD FOR PRODUCING SYNTHETIC RESIN USING SAID SOLVENT KJ Chemicals Corporation (JP) 2023-07-19 EP disclosed
CN-116075537-A Solvent for resin synthesis and method for producing synthetic resin using the same 科巨希化学股份有限公司 2023-05-05 CN disclosed
WO-2022054850-A1 SOLVENT FOR RESIN SYNTHESIS AND METHOD FOR PRODUCING SYNTHETIC RESIN USING SAID SOLVENT KJケミカルズ株式会社 2022-03-17 WO disclosed
US-11274083-B2 Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents SYNGENTA CROP PROTECTION AG (CH) 2022-03-15 US disclosed
EP-3728235-B1 SUBSTITUTED THIOPHENYLURACILS , THEIR SALTS AND USE OF SAID COMPOUNDS AS HERBICIDAL AGENTS SYNGENTA CROP PROTECTION AG (CH) 2022-02-09 EP disclosed
US-20210087151-A1 SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS SYNGENTA CROP PROTECTION AG (CH) 2021-03-25 US disclosed
US-10874673-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-12-29 US disclosed
US-20190151314-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED 2019-05-23 US disclosed
US-10039762-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-08-07 US disclosed
US-20180078553-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED 2018-03-22 US disclosed
US-9808459-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-11-07 US disclosed
US-20170100400-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED 2017-04-13 US disclosed
EP-2582705-A1 ANELLATED PYRIDINE COMPOUNDS AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS F.HOFFMANN-LA ROCHE AG (CH) 2013-04-24 EP disclosed
WO-2011161009-A1 ANELLATED PYRIDINE COMPOUNDS AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-29 WO disclosed
WO-2010148197-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180078553-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION ACE, IRF3, ACE2 NPSR1 2470/4885MAPT 3275/4885SMN1; SMN2 2932/4885
US-20190151314-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION ACE, IRF3, ACE2 NPSR1 2470/4885MAPT 3275/4885SMN1; SMN2 2932/4885
US-11274083-B2 Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents UNG, TYMP, TYMS NPSR1 3414/4885MAPT 2779/4885SMN1; SMN2 4822/4885
US-20210087151-A1 SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS UNG, TYMP, TYMS NPSR1 3414/4885MAPT 2779/4885SMN1; SMN2 4822/4885
US-10874673-B2 Inhibitors of influenza viruses replication ACE, IRF3, ACE2 NPSR1 2470/4885MAPT 3275/4885SMN1; SMN2 2932/4885
US-10039762-B2 Inhibitors of influenza viruses replication ACE, IRF3, ACE2 NPSR1 2470/4885MAPT 3275/4885SMN1; SMN2 2932/4885
US-20170100400-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION ACE, IRF3, ACE2 NPSR1 2470/4885MAPT 3275/4885SMN1; SMN2 2932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.